MedPath
TGA Approval

Hospira Desferrioxamine mesilate for Injection BP, 500 mg (162013)

162013

Hospira Desferrioxamine mesilate for Injection BP, 500 mg

Hospira Australia Pty Ltd

May 27, 2009

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

desferrioxamine mesilate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.